The Driven Brands collision group announced its monumental North American milestone of raising over $5 million for cystic fibrosis research, care, and advocacy.Read More
All media inquiries can be directed to email@example.com or by calling 1-800-378-2233.
Provinces and territories have begun funding for younger age group following positive recommendation from CADTH.
Cystic Fibrosis Canada celebrated Giving Tuesday with the launch of its annual holiday fundraising campaign, One Day, Now.Read More
Cystic Fibrosis Canada calls on jurisdictions to fund the drug immediately for all who can benefit, and eliminate deductibles around accessRead More
Toronto, Ontario – Cystic Fibrosis Canada has awarded $250,000 in seed grants to five researchers to encourage new and innovative research projects in support of the organization’s pledge to go further in fueling targeted, world-class cystic fibrosis (CF) research.Read More
Last week at CARSTAR’s annual Evolution Conference in Montreal, Quebec, Cystic Fibrosis Canada and the collision and glass service organization celebrated the milestone of 25 years of partnership.Read More
Cystic Fibrosis Canada’s Chief Scientific Officer, Dr. Paul Eckford, recently attended the European CF Society’s annual conference where important advances in research and clinical care were shared.Read More
Cystic Fibrosis Canada’s Healthcare Advisory Council has published recommendations for the follow-up of pregnancies and newborns of mothers who are receiving cystic fibrosis transmembrane conductance regulator (CFTR) modulators, like Trikafta.Read More
Cystic Fibrosis Canada has awarded nearly $2.7M in research funding to projects that support the organization’s new approach to research funding, aimed at improving health outcomes for people living with cystic fibrosis (CF).Read More
Cystic Fibrosis Canada’s Healthcare Advisory Committee (HAC) has published standardized Canadian care guidelines?for the diagnosis and treatment of pulmonary exacerbations in patients with cystic fibrosis.Read More